Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmati Aim Vct Regulatory News (AMAT)

  • There is currently no data for AMAT

Offer for Subscription - Update

4 Aug 2021 15:30

RNS Number : 6032H
Amati AIM VCT PLC
04 August 2021
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR ANY JURISDICTION FOR WHICH THE SAME COULD BE UNLAWFUL. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION, INCLUDING IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA.

 

Amati AIM VCT plc

4 August 2021

 

Amati AIM VCT plc (the "Company")

Legal Entity Identifier: 213800HAEDBBK9RWCD25

Offer for subscription - Update

The Board of Amati AIM VCT plc (the "Company") announced on 28 July 2021 that the Company had published a prospectus (the "Prospectus") in connection with proposals to raise up to £40 million (with an over-allotment facility to raise up to a further £25 million), by way of an offer for subscription of new ordinary shares (the "Offer") (the "New Shares").

The Board has been advised that, on the basis of applications received, the Company has successfully raised £40 million under the Offer. The Board does not intend to utilise the over-allotment facility at the current time, but the Investment Manager is closely monitoring potential investment opportunities and, if it is felt appropriate, the Company will seek to raise further funds under the over-allotment facility prior to the Offer closing.

The first allotment of New Shares is expected to be on or around 9 August 2021. Dealings in the New Shares issued under this allotment are expected to become effective on 23 August 2021. The Company is no longer accepting applications in relation to the Offer. Investors whose applications are received after the Company raised £40 million will have their subscription monies returned in accordance with the terms and conditions of the Offer. If the over-allotment facility is to be utilised, the Company will make a further RNS announcement detailing the application process.

For further information, please contact the investor line at Amati Global Investors on 0131 503 9115 or by email at info@amatiglobal.com.

Notes

This announcement does not constitute or form part of any offer to issue or sell, or any solicitation of any offer to subscribe for or purchase, any investment in any jurisdiction, nor shall it (or the fact of its distribution) form the basis of, or be relied on in connection with, any contract therefor.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDUPUBPRUPGGCC
Date   Source Headline
1st Feb 20234:33 pmRNSNet Asset Value(s)
1st Feb 202311:00 amRNSTotal Voting Rights
27th Jan 20233:16 pmRNSNet Asset Value(s)
20th Jan 20234:54 pmRNSTransaction in Own Shares
20th Jan 20233:03 pmRNSNet Asset Value(s)
20th Jan 202310:54 amRNSDirector/PDMR Shareholding
13th Jan 20233:27 pmRNSNet Asset Value(s)
6th Jan 20233:53 pmRNSNet Asset Value(s)
6th Jan 202311:42 amRNSTransaction in Own Shares
3rd Jan 20234:49 pmRNSNet Asset Value(s)
3rd Jan 20239:33 amRNSTotal Voting Rights
23rd Dec 202210:53 amRNSNet Asset Value(s)
22nd Dec 20224:15 pmRNSTransaction in Own Shares
16th Dec 20222:27 pmRNSNet Asset Value(s)
9th Dec 20224:52 pmRNSNet Asset Value(s)
6th Dec 20224:44 pmRNSTransaction in Own Shares
1st Dec 20224:52 pmRNSNet Asset Value(s)
1st Dec 20224:39 pmRNSBoard Committee Change
1st Dec 20224:19 pmRNSTotal Voting Rights
28th Nov 202210:35 amRNSDirector/PDMR Shareholding
25th Nov 20224:56 pmRNSIssue of Equity - DRIS
25th Nov 20223:29 pmRNSNet Asset Value(s)
21st Nov 20222:52 pmRNSTransaction in Own Shares
18th Nov 20224:15 pmRNSNet Asset Value(s)
11th Nov 20223:42 pmRNSNet Asset Value(s)
4th Nov 20222:40 pmRNSNet Asset Value(s)
1st Nov 20225:32 pmRNSNet Asset Value(s)
1st Nov 202210:06 amRNSTotal Voting Rights
24th Oct 202210:45 amRNSNet Asset Value(s)
21st Oct 20223:09 pmRNSTransaction in Own Shares
17th Oct 202212:04 pmRNSNet Asset Value(s)
12th Oct 20225:19 pmRNSTransaction in Own Shares
10th Oct 20222:40 pmRNSNet Asset Value(s)
4th Oct 20221:50 pmRNSNet Asset Value(s)
3rd Oct 20229:16 amRNSTotal Voting Rights
30th Sep 20227:01 amRNSDividend Declaration
30th Sep 20227:00 amRNSHalf-year Report
28th Sep 20223:02 pmRNSTransaction in Own Shares
23rd Sep 20224:09 pmRNSNet Asset Value(s)
23rd Sep 20223:56 pmRNSTransaction in Own Shares
22nd Sep 202210:53 amRNSTransaction in Own Shares
16th Sep 20225:19 pmRNSNet Asset Value(s)
13th Sep 20223:10 pmRNSCancellation of Share Premium Account
9th Sep 20223:02 pmRNSNet Asset Value(s)
7th Sep 20221:56 pmRNSTransaction in Own Shares
2nd Sep 202210:40 amRNSReplacement Total Voting Rights
1st Sep 20225:08 pmRNSTotal Voting Rights
1st Sep 20224:26 pmRNSTransaction in Own Shares
1st Sep 20223:48 pmRNSNet Asset Value(s)
30th Aug 20224:14 pmRNSCompliance with Market Abuse Regulation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.